查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827368

按動物類型、產品、治療用途、分銷管道和最終用戶分類的動物保健市場 - 2025-2032 年全球預測

Animal Health Market by Animal Type, Product, Therapeutic Application, Distribution Channel, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動物保健市場將成長至 1,763 億美元，複合年成長率為 8.67%。

主要市場統計數據
基準年2024年 906.2億美元
預計2025年 985億美元
預測年份：2032年 1763億美元
複合年成長率（%） 8.67%

對不斷發展的動物健康生態系統的簡要介紹，重點關注重塑臨床實踐、供應鏈和相關人員之間合作的促進因素

現代動物健康是公共衛生、食品安全和伴侶動物福利之間的關鍵連結。寵物數量的增加、畜牧業生產體系的集約化以及公眾對通用感染疾病風險的日益認知，正在推動對強效預防和治療解決方案的需求。同時，監管監督和管理工作正在重塑產品在不同物種和不同用途的開發、核准和部署方式。

人類和動物健康優先事項的融合正在推動獸醫、生產者和公共衛生當局之間更緊密的合作，從而強化「同一個健康」框架。診斷、生技藥品和數據分析領域的技術進步使得更早發現疾病、採取更有針對性的干涉措施以及更好地監測治療結果成為可能，而主導對永續性、透明度和減少抗菌藥物使用的偏好正在影響產品開發路徑和商業策略。

隨著該行業逐漸擺脫傳統模式，它強調透過多元化供應鏈、數位化服務交付以及跨部門研發夥伴關係來增強韌性。這些趨勢迫使相關人員重新評估研究、製造、分銷和現場服務方面的能力。隨著新技術和政策變化的融合，領導者必須在當前臨床需求與長期策略定位之間取得平衡，以保護動物健康和相關的人類健康目標。

重大的結構和技術變革正在重新定義整個動物保健產業的產品創新、臨床實踐和分銷管道

該行業正處於一場變革性轉變之中，這場轉變正在重新定義臨床實踐、研究重點和商業模式。數位轉型正在加速伴侶動物遠端醫療平台和牲畜遠端監控工具的普及，使臨床醫生和生產者能夠做出更快、更準確、數據主導的決策。精準畜牧養殖技術，包括感測器和基因組分析工具，正在最佳化生產力和飼料效率，同時透過早期療育降低疾病發病率。

在產品創新方面，生技藥品和重組疫苗平台以及使分子檢測更貼近臨床的新一代診斷技術正日益受到關注。支持腸道健康和免疫力的飼料添加劑也日益受到關注，這反映出減少對傳統抗生素依賴的廣泛趨勢。同時，法規和抗菌藥物管理計劃正在推動對替代療法以及更嚴格的標籤和使用通訊協定的需求。

從商業性來看，供應商之間的整合以及藥物開發商和技術提供者之間的策略聯盟正在重塑競爭動態。不斷發展的分銷管道，包括線上銷售和直接面對消費者的模式，正在改變飼主和獸醫獲取產品的方式。因此，那些兼具技術力、監管前瞻性和以客戶為中心的分銷模式的組織將在不同的物種和市場中獲得差異化的價值。

評估美國關稅政策的變化將如何再形成動物健康利益相關人員的供應鏈、採購決策和定價動態

預計2025年美國關稅政策的調整將對動物保健產業產生複雜的影響，其影響遠不止眼前的成本壓力。關稅變化往往會增加進口原料和成品的到岸成本，這可能會擠壓依賴國際供應鏈的製造商的淨利率。為此，企業通常會重新評估籌資策略，轉向較近的供應商或擴大國內產能，以降低貿易政策波動帶來的風險。

這些調整也將影響疫苗成分、診斷劑和特種飼料添加劑等關鍵投入的物流和時間安排。通關時間和文件要求的增加可能會造成暫時的瓶頸，影響生技藥品的低溫運輸連續性和對時間敏感的臨床診斷產品的交付。因此，分銷合作夥伴和獸醫診所可能會採取更保守的庫存策略，增加營運資金需求，並需要更複雜的需求預測能力。

貿易政策的變化往往會引發市場重組，有些國家會將出口流從受關稅影響的路線轉移，而有些國家則會利用其競爭優勢來填補供應缺口。企業應採取的積極措施包括重新設計採購合約以納入關稅轉嫁條款、投資於關稅分類專業知識，以及在區域樞紐尋求策略性庫存緩衝。平衡成本回收與客戶支付意願的定價策略至關重要，與最終用戶的透明溝通對於在成本調整期間維持信任至關重要。從中期來看，擁有多元化供應鏈、靈活製造和商業性敏捷性的企業可能最有能力吸收政策衝擊，同時繼續有效地服務獸醫、生產商和飼主。

從全面的細分框架中獲得洞察，該框架可識別物種、產品形態、治療用途、分銷管道和最終用戶行為

細緻的細分框架揭示了臨床需求、機會和營運複雜性在動物保健產品組合中的交匯點。按動物類型分類，市場涵蓋伴侶動物和牲畜。伴侶動物細分市場主要關注犬和貓，其核心是預防保健、診斷和慢性疾病管理。而牲畜細分市場則包括水產養殖、牛、家禽和豬，每種動物都有特定的生物安全、疫苗接種和飼料管理重點，這些重點反映了它們的生產系統和疾病風險狀況。

我們的產品包括診斷產品、飼料添加劑、抗寄生蟲藥、藥品和疫苗。診斷產品分為免疫學方法和分子生物學方法，分別用於即時篩檢和更深入的基因組分析。飼料添加劑包括酵素、益生元和益生菌，以促進最佳消化和恢復；抗寄生蟲藥物包括針對特定物種寄生蟲量身定做的體外寄生蟲藥和體內寄生蟲藥物。藥品分為品牌藥和非專利藥；疫苗包括去活化疫苗、減毒疫苗和重組疫苗，並採取不同的生產和監管途徑。

依治療用途細分，明確了感染疾病、抗發炎藥、抗寄生蟲藥和荷爾蒙藥物的臨床定位。感染疾病進一步分為抗生素、抗真菌藥物和抗病毒藥，管理壓力影響其使用。抗發炎藥物分為皮質類固醇和非類固醇抗發炎藥，反映了療效和安全性之間的權衡。抗寄生蟲藥包括體外寄生蟲藥和體內寄生蟲藥，而荷爾蒙藥物包括生長激素和生殖激素，主要用於生產。

分銷通路細分揭示了影響覆蓋範圍和服務模式的市場路徑變化。網路商店正在分化為直銷網站和第三方平台，擴大了訪問管道並提升了便利性。零售藥局（包括連鎖藥局和獨立藥局）對寵物飼主仍然至關重要，而獸醫診所和診所（從大型動物醫院到小型動物診所）在處方和治療管理方面仍然發揮著重要作用。最終用戶細分將動物主人、飼料製造商和獸醫確定為關鍵決策者，其中動物主人包括畜牧養殖戶和寵物主人，獸醫分為大型動物、混合動物和小型動物執業獸醫，每種類型都影響著產品的選擇和採取路徑。

影響全球動物保健市場產品採用、供應鏈設計和商業化策略的區域動態和法規環境

區域動態對整個動物保健市場的法規、供應鏈和採用率有重大影響。美洲地區呈現出多元化的特徵，包括完善的法律規範、成熟的伴侶動物照護市場以及對生物安全有嚴格要求的大型商業畜牧養殖場。在該地區，私人獸醫診所和一體化生產系統推動了對診斷、疫苗和飼料最佳化解決方案的需求，而數位管道也日益成為傳統分銷網路的補充。

歐洲、中東和非洲 歐洲、中東和非洲呈現出多元化的格局，受許多歐洲市場嚴格的監管條件、日益普及的監管框架以及中東和非洲地區生產體系的差異性影響。該地區的需求優先考慮高品質的疫苗、診斷試劑和抗菌藥物管理，以及針對小農戶和商業生產者的客製化支援。各國基礎設施的差異凸顯了製定靈活配送和低溫運輸策略的必要性。

亞太地區的特點是生產系統快速現代化，水產養殖業活性化，伴侶動物照護市場不斷發展。本地生產和研發投資不斷成長，同時又依賴跨境貿易獲取專業投入。監管改革、監管能力提升以及私營部門的大力參與，正在加速先進生技藥品和分子診斷技術的推廣應用。在各個地區，企業必須根據法規環境、通路結構以及獸醫、生產商和飼主的不同需求，制定相應的商業性策略。

產業領導者採用的策略策略，重點在於創新、供應鏈彈性和現代化市場競爭，以保持競爭優勢

該產業的主要企業正在採取策略態勢，強調加強研發、產品組合多元化和通路創新。各公司正將資源配置到新型疫苗平台和分子診斷領域，同時拓展生技藥品的能力，以解決飼料添加劑和抗菌藥物管理的問題。藥物開發商和技術供應商之間的策略合作夥伴關係將促進診斷驅動的治療途徑與數位醫療服務的快速整合。

在商業方面，企業正在透過向醫療保健提供者直銷和數位銷售管道相結合的方式最佳化分銷。投資低溫運輸物流和本地製造能力可以降低供應中斷和貿易政策變化帶來的風險。同時，一些企業正在選擇性地進行併購，以獲取互補技術，增強其在高成長領域的影響力，並確保進入區域市場。

先進的品質系統、法規專業知識以及可擴展的製造外包關係有助於加快產品上市和生命週期管理。能夠平衡創新與切合實際的供應鏈和商業化策略的公司更有可能保持競爭力。此外，透過培訓、技術支援和性能數據共用與獸醫和生產商持續合作，可以強化產品價值提案並推動產品採用。

為高階主管提供高影響力的實用行動，以增強動物健康的復原力，加速數位化應用，並推動臨床和商業性成果

動物保健產業的領導者應採取果斷可行的措施，抓住機遇，降低當前動態環境的風險。首先，優先考慮靈活的生產和供應商多元化，以減少受政策主導的中斷和物流波動的影響。這包括檢驗關鍵投入的替代來源，投資本地生技藥品填充能力，以及協商允許根據投入成本波動調整價格的合約。

其次，我們正在加速數位轉型計劃，以連接診斷和治療途徑，並為伴侶動物和牲畜提供遠端醫療和遠端舉措。將診斷數據與治療通訊協定相結合，將改善臨床結果，並支持與付款人和生產者進行基於價值的對話。第三，我們正在投資抗菌藥物管理和替代治療方案，並將這些努力與針對獸醫和生產者的教育計畫結合，以促進負責任的使用並滿足監管要求。

第四，我們將根據地區和最終用戶定製商業模式，將與獸醫的直接互動、寵物飼主主人的數位化DTC體驗以及與飼料製造商的策略夥伴關係相結合。最後，我們將把永續性和透明度融入我們的產品生命週期中。協同實施這些措施將增強韌性，加速產品採用，並在我們的產品組合中創造可衡量的價值。

一種透明、多方法的研究途徑，結合了初步訪談、二次證據的整合和嚴格的三角測量來支持策略性發現

本研究結合定性和定量方法，提供嚴謹且可操作的分析。初步研究包括對獸醫、生產經理、採購專業人員和行業專家的結構化訪談，以了解臨床需求、採購促進因素和分銷挑戰的實地觀點。此外，我們也進行了二次研究，利用監管文件、科學文獻、專利申請和上市公司資訊揭露，揭示技術發展軌跡和競爭定位。

數據三角測量技術檢驗了不同來源的洞察，並確保了實地回饋與記錄趨勢之間的一致性。細分分析運用物種、產品形態、治療用途、分銷管道和最終用戶的視角，突顯差異化的機會和限制因素。區域評估將政策審查與物流和基礎設施分析相結合，以揭示各區域如何影響採用和供應鏈設計。

透過反覆的假設檢驗、同儕審查和情境分析，對貿易政策影響和技術採用的假設進行壓力測試，以保持分析的嚴謹性。限制包括不同司法管轄區的監管時間表存在差異，以及某些區域的數據品質參差不齊。這些問題的解決方式是：使假設透明化，並在二手資料稀缺的情況下優先考慮關鍵相關人員的意見。出於道德方面的考慮，確保了所有受訪者的保密性和自願參與。

簡潔的產業動態綜合，強調創新、監管和營運彈性之間的相互作用，這將推動未來的動物健康策略

總而言之，在技術創新、法規演變和商業模式轉變的推動下，動物保健產業正經歷一場根本性的重構。診斷和疫苗平台的發展、數位醫療和精準畜牧業的興起，以及對抗菌藥物管理的日益重視，正在全面重塑產品開發和服務交付。同時，供應鏈的韌性和區域策略對於保障基本治療和預防藥物的可近性至關重要。

業界參與者若能將研發重點與管理目標結合，投資於靈活的生產和本地分銷，並部署以客戶為中心的數位化服務，將更有利於獲取長期價值。同樣重要的是，積極主動地與監管機構和獸醫界溝通，確保新治療方法在臨床上可接受並符合法規要求。將切實可行的營運措施與創新策略投資結合，將使企業能夠安然度過短期政策動盪，同時打造永續的競爭優勢。

展望未來，公共和私營部門之間的持續合作以及基於證據的商業化和負責任的使用實踐對於改善動物健康結果、保護公眾健康和支持永續的糧食系統至關重要。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 整合精準畜牧技術，實現大規模酪農養殖的即時健康監測
  • 加速採用 mRNA 疫苗平台，以應對獸醫學中新出現的通用感染疾病
  • 實施人工智慧驅動的決策支援系統，最佳化伴侶動物治療通訊協定
  • 擴大畜牧生產中的抗菌藥物管理項目，以應對日益嚴重的抗生素抗藥性
  • 增加微生物組調節療法的投資，以取代傳統的家禽生長促進劑
  • 遠端醫療和遠距離診斷在農村獸醫實踐和畜群管理中的進展
  • 基於區塊鏈的供應鏈追蹤解決方案的出現，確保動物產品來源的透明度
  • 監管協調努力簡化創新生技藥品的全球核准流程
  • 人們對氣候適應性營養策略的興趣日益濃厚，以提高動物對環境壓力的適應能力
  • 開發用於牲畜預防和治療的物種特異性單株抗體療法

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第 8 章：動物保健市場（按動物類型）

  • 伴侶動物
    • 貓
    • 狗
  • 家畜
    • 水產養殖
    • 牛
    • 家禽
    • 豬

第9章動物保健產品市場

  • 診斷
    • 免疫學診斷
    • 分子診斷
  • 飼料添加劑
    • 酵素
    • 益生元
    • 益生菌
  • 殺寄生蟲劑
    • 殺外寄生蟲劑
    • 體內殺寄生蟲劑
  • 製藥
    • 品牌
    • 學名藥
  • 疫苗
    • 去活化疫苗
    • 活病毒疫苗
    • 重組

第 10 章：依治療用途分類的動物保健市場

  • 抗感染藥物
    • 抗生素
    • 抗真菌藥物
    • 抗病毒藥物
  • 抗發炎藥物
    • 皮質類固醇
    • NSAIDs
  • 抗寄生蟲藥
    • 殺外寄生蟲劑
    • 體內殺寄生蟲劑
  • 荷爾蒙治療藥物
    • 生長激素
    • 生殖荷爾蒙

第 11 章動物保健市場（依分銷管道）

  • 網路商店
    • 消費者網站
    • 第三方平台
  • 零售藥局
    • 連鎖藥局
    • 獨立藥房
  • 獸醫醫院和診所
    • 大型動物醫院
    • 小動物診所

第 12 章動物保健市場（按最終用戶）

  • 動物飼主
    • 畜牧養殖戶
    • 寵物飼主
  • 飼料生產商
  • 獸醫
    • 大型動物獸醫
    • 混合執業獸醫
    • 小動物獸醫

第13章動物保健市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章動物保健市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。按國家/地區分類的動物保健市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Zoetis Inc.
    • Merck & Co., Inc.
    • Boehringer Ingelheim International GmbH
    • Elanco Animal Health Incorporated
    • IDEXX Laboratories, Inc.
    • Ceva Sante Animale SA
    • Vetoquinol SA
    • Virbac SA
    • Dechra Pharmaceuticals PLC
    • Phibro Animal Health Corporation
Product Code: MRR-434CCDA04CF9

The Animal Health Market is projected to grow by USD 176.30 billion at a CAGR of 8.67% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 90.62 billion
Estimated Year [2025] USD 98.50 billion
Forecast Year [2032] USD 176.30 billion
CAGR (%) 8.67%

A concise orientation to the evolving animal health ecosystem highlighting drivers that reshape clinical practice, supply chains, and stakeholder collaborations

The contemporary animal health landscape occupies a critical nexus between public health, food security, and companion animal welfare. Rising pet ownership, intensifying livestock production systems, and heightened public awareness of zoonotic risks have elevated demand for robust preventive and therapeutic solutions. At the same time, regulatory scrutiny and stewardship initiatives are reshaping how products are developed, approved, and deployed across species and use cases.

Integration of human and animal health priorities has prompted closer collaboration among veterinarians, producers, and public health authorities, strengthening the One Health framework. Technological advances in diagnostics, biologics, and data analytics are enabling earlier detection of disease, more precise interventions, and improved monitoring of treatment outcomes. Meanwhile, consumer-driven preferences for sustainability, transparency, and reduced antimicrobial use are influencing product development pathways and commercial strategies.

Transitioning from traditional models, the sector now emphasizes resilience: diversified supply chains, digital-enabled service delivery, and cross-disciplinary R&D partnerships. These trends require stakeholders to reassess capabilities across research, manufacturing, distribution, and field services. As emerging technologies and policy shifts converge, leaders must balance immediate clinical needs with long-term strategic positioning to safeguard animal health and related human health objectives.

Major structural and technological shifts are redefining product innovation, clinical practice, and distribution channels across the animal health industry

The industry is in the midst of transformative shifts that are redefining clinical practice, research priorities, and commercial models. Digital transformation is accelerating adoption of telemedicine platforms for companion animals and remote monitoring tools for livestock, enabling clinicians and producers to make data-driven decisions with greater speed and precision. Precision livestock farming technologies, including sensors and genomic tools, are reducing disease incidence through earlier intervention while optimizing productivity and feed efficiency.

In product innovation, biologics and recombinant vaccine platforms are gaining traction alongside next-generation diagnostics that bring molecular testing closer to point-of-care settings. There is also a clear pivot toward feed additives that support gut health and immunity, reflecting a broader move to reduce reliance on traditional antibiotics. Concurrently, regulatory and antimicrobial stewardship programs are increasing demand for alternative therapies and tightened labeling and usage protocols.

Commercially, consolidation among suppliers and strategic partnerships between pharmaceutical developers and technology providers are reshaping competitive dynamics. Evolving distribution channels, notably online sales and direct-to-consumer models, are changing how owners and veterinarians access products. As a result, organizations that integrate technological capability, regulatory foresight, and customer-centric distribution will capture differentiated value across species and markets.

Assessing how shifts in United States tariff policy could reshape supply chains, procurement decisions, and pricing dynamics for animal health stakeholders

Anticipated adjustments to United States tariff policy in 2025 present a complex set of implications for the animal health sector that extend beyond immediate cost pressures. Tariff changes tend to increase the landed cost of imported raw materials and finished products, which can compress margins for manufacturers reliant on international supply chains. In response, firms often reassess sourcing strategies, shifting toward nearer-shore suppliers or expanding domestic manufacturing capacity to mitigate exposure to trade policy volatility.

These adjustments also influence the logistics and timing of critical inputs such as vaccine components, diagnostic reagents, and specialized feed additives. Heightened customs clearance times and documentation requirements can create temporary bottlenecks that affect cold-chain continuity for biologics and time-sensitive deliveries for clinical diagnostics. As a consequence, distribution partners and veterinary clinics may adopt more conservative inventory practices, which can increase working capital needs and require more sophisticated demand forecasting capabilities.

Trade policy shifts frequently catalyze market realignment, with some countries diverting export flows away from tariff-affected routes and others capitalizing on competitive advantages to fill supply gaps. For companies, proactive measures include redesigning procurement contracts to include tariff pass-through clauses, investing in tariff classification expertise, and pursuing strategic inventory buffers at regional hubs. Importantly, pricing strategies must balance cost recovery with customer willingness to pay, and transparent communication with end users is essential to maintain trust during periods of cost adjustment. Over the medium term, firms that combine supply chain diversification, flexible manufacturing, and commercial agility will be best positioned to absorb policy-driven shocks while continuing to serve veterinarians, producers, and pet owners effectively.

Insights derived from a comprehensive segmentation framework that clarifies species, product modalities, therapeutic uses, distribution channels, and end-user behaviors

A nuanced segmentation framework reveals where clinical need, commercial opportunity, and operational complexity intersect across animal health portfolios. When viewed by animal type, the market spans companion animals and livestock; the companion animal segment concentrates on cats and dogs where preventive care, diagnostics, and chronic disease management dominate, while the livestock segment includes aquaculture, cattle, poultry, and swine, each with specific biosecurity, vaccination, and feed management priorities that reflect production systems and disease risk profiles.

Product-focused segmentation distinguishes diagnostics, feed additives, parasiticides, pharmaceuticals, and vaccines. Diagnostics bifurcate into immunological and molecular methods, enabling point-of-care screening and deeper genomic insights respectively. Feed additives encompass enzymes, prebiotics, and probiotics aimed at optimizing digestion and resilience, whereas parasiticides include ectoparasiticides and endoparasiticides tailored to species-specific parasite burdens. Pharmaceuticals split into branded and generic offerings, while vaccines cover killed inactivated, live attenuated, and recombinant formats with divergent manufacturing and regulatory pathways.

Therapeutic application segmentation clarifies clinical positioning across anti-infectives, anti-inflammatories, antiparasitics, and hormonal therapeutics. Anti-infectives further differentiate into antibiotics, antifungals, and antivirals, with stewardship pressures influencing use profiles. Anti-inflammatories are divided into corticosteroids and NSAIDs, reflecting efficacy and safety trade-offs. Antiparasitics include both ecto- and endoparasiticides, and hormonal therapeutics encompass growth and reproductive hormones used primarily in production settings.

Distribution channel segmentation exposes the shifting routes to market that affect reach and service models. Online stores, split between direct-to-consumer websites and third-party platforms, are expanding access and convenience; retail pharmacies, including chain and independent outlets, remain important for pet owners; and veterinary hospitals and clinics, ranging from large animal hospitals to small animal clinics, continue to be pivotal for prescribing and administering treatments. End-user segmentation identifies animal owners, feed manufacturers, and veterinarians as primary decision-makers, with animal owners comprising livestock farmers and pet owners, and veterinarians categorized into large animal, mixed practice, and small animal practitioners, each influencing product selection and adoption pathways.

Regional dynamics and regulatory environments that shape product adoption, supply chain design, and commercialization strategies across global animal health markets

Regional dynamics exert a strong influence on regulation, supply chains, and adoption rates across animal health markets. The Americas region presents a diverse profile: established regulatory frameworks, mature companion animal care markets, and large-scale commercial livestock operations with intensive biosecurity needs. In this geography, private veterinary practice and integrated production systems drive demand for diagnostics, vaccines, and feed optimization solutions, while digital channels increasingly supplement traditional distribution networks.

Europe, Middle East & Africa exhibits a multifaceted landscape shaped by stringent regulatory standards in many European markets, rising adoption of stewardship frameworks, and heterogeneity across Middle Eastern and African production systems. Demand in this region tends to prioritize high-quality vaccines and diagnostics, antimicrobial stewardship, and tailored support for smallholder and commercial producers. Infrastructure variability across countries underscores the need for adaptable distribution and cold-chain strategies.

The Asia-Pacific region is characterized by rapid modernization of production systems, significant aquaculture activity, and evolving companion animal care markets. Growing investment in local manufacturing and R&D coexists with reliance on cross-border trade for specialized inputs. Regulatory reform, increasing regulatory capacity, and strong private sector participation are accelerating uptake of advanced biologics and molecular diagnostics. Across regions, companies must tailor commercial approaches to regulatory environments, channel structures, and the varying priorities of veterinarians, producers, and pet owners.

Strategic playbooks adopted by industry leaders focusing on innovation, supply chain resilience, and go-to-market modernization to maintain competitive advantage

Leading companies in the sector are adopting strategic postures that emphasize R&D intensity, portfolio diversification, and channel innovation. Firms are allocating resources toward novel vaccine platforms and molecular diagnostics while expanding capabilities in feed additives and biologics that address antimicrobial stewardship concerns. Strategic alliances between pharmaceutical developers and technology vendors enable faster integration of diagnostic-guided treatment pathways and digital health services.

Commercially, organizations are optimizing distribution through a mix of direct-to-clinic relationships and digital sales channels. Investments in cold-chain logistics and regional manufacturing capacities reduce exposure to supply disruptions and trade policy shifts. In parallel, some companies are pursuing selective M&A to acquire complementary technologies, strengthen presence in high-growth species segments, or secure access to regional markets.

Operational excellence remains a priority: advanced quality systems, regulatory affairs expertise, and scalable contract manufacturing relationships support faster product launches and lifecycle management. Companies that balance innovation with pragmatic supply chain and commercialization strategies will sustain competitiveness. Moreover, sustained engagement with veterinarians and producers-through training, technical support, and performance data-sharing-reinforces product value propositions and drives adoption.

Practical high-impact actions for company executives to strengthen resilience, accelerate digital adoption, and drive clinical and commercial outcomes in animal health

Leaders in animal health should take decisive, actionable steps to capture opportunity and mitigate risk across a dynamic landscape. First, prioritize flexible manufacturing and supplier diversification to reduce exposure to policy-driven disruptions and logistics volatility. This includes validating alternative sources for critical inputs, investing in regional fill-finish capacity for biologics, and negotiating contracts that allow pricing adjustments aligned with input cost fluctuations.

Second, accelerate digital transformation initiatives that connect diagnostics to care pathways and enable telemedicine and remote monitoring for both companion animals and livestock. Integrating diagnostic data with treatment protocols enhances clinical outcomes and supports value-based conversations with payers and producers. Third, invest in antimicrobial stewardship and alternative therapeutics, pairing these efforts with educational programs for veterinarians and producers to drive responsible use and meet regulatory expectations.

Fourth, tailor commercial models by region and end user, combining direct engagement with veterinarians, digital DTC experiences for pet owners, and strategic partnerships with feed manufacturers. Finally, embed sustainability and transparency into product lifecycles-ranging from raw material sourcing to packaging choices-to address customer and regulatory demands and to differentiate brands over the long term. Implementing these actions in a coordinated manner will strengthen resilience, accelerate adoption, and create measurable value across portfolios.

A transparent, multi-method research approach combining primary interviews, secondary evidence synthesis, and rigorous triangulation to underpin strategic findings

This research synthesizes qualitative and quantitative approaches to produce a rigorous, actionable analysis. Primary research included structured interviews with veterinarians, production managers, procurement professionals, and industry experts to capture frontline perspectives on clinical needs, purchasing drivers, and distribution challenges. Complementing this, secondary research drew on regulatory publications, scientific literature, patent filings, and publicly available company disclosures to map technological trajectories and competitive positioning.

Data triangulation techniques validated insights across sources, ensuring consistency between field feedback and documented trends. Segmentation analyses employed species, product modality, therapeutic application, distribution channel, and end-user lenses to surface differentiated opportunities and constraints. Regional assessments combined policy reviews with logistics and infrastructure analyses to determine how geography shapes adoption and supply chain design.

Analytical rigor was maintained through iterative hypothesis testing, peer review, and scenario analysis to stress-test assumptions related to trade policy impacts and technology adoption. Limitations include variability in regulatory timelines across jurisdictions and heterogeneous data quality in certain regional contexts; these were addressed by transparency in assumptions and by prioritizing primary stakeholder input where secondary data were sparse. Ethical considerations upheld confidentiality and voluntary participation for all interview subjects.

A concise synthesis of sector dynamics that highlights the interplay of innovation, regulation, and operational resilience driving future animal health strategies

In conclusion, the animal health sector is experiencing a fundamental reconfiguration driven by technological innovation, regulatory evolution, and shifting commercial models. Advances in diagnostics and vaccine platforms, the rise of digital health and precision livestock farming, and growing emphasis on antimicrobial stewardship collectively reshape product development and service delivery. Simultaneously, supply chain resilience and regional strategy have become central to sustaining access to essential therapeutics and preventive products.

Industry participants that align R&D priorities with stewardship goals, invest in flexible manufacturing and regional distribution, and deploy customer-centric digital offerings will be better positioned to capture long-term value. Equally important is proactive engagement with regulatory authorities and veterinary communities to ensure that new modalities achieve clinical acceptance and regulatory compliance. By synthesizing practical operational measures with strategic investment in innovation, organizations can navigate near-term policy disruptions while building durable competitive advantage.

Looking forward, continued collaboration across the public and private sectors, coupled with evidence-driven commercialization and responsible use practices, will be essential to advancing animal health outcomes, protecting public health, and supporting sustainable food systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of precision livestock farming technologies for real-time health monitoring in large dairy operations
  • 5.2. Accelerated adoption of mRNA vaccine platforms to address emerging zoonotic threats in veterinary care
  • 5.3. Implementation of artificial intelligence-driven decision support systems for optimized treatment protocols in companion animals
  • 5.4. Expansion of antimicrobial stewardship programs in livestock production to combat rising antibiotic resistance
  • 5.5. Increasing investment in microbiome modulation therapies as alternatives to traditional growth promoters in poultry
  • 5.6. Advancements in telehealth and remote diagnostics for rural veterinary practice and livestock herd management
  • 5.7. Emergence of blockchain-based supply chain traceability solutions to ensure transparency in animal product origin
  • 5.8. Regulatory harmonization efforts to streamline global approval pathways for innovative animal health biologics
  • 5.9. Growing focus on climate-adaptive nutrition strategies to improve animal resilience against environmental stressors
  • 5.10. Development of species-specific monoclonal antibody therapies for preventive and therapeutic applications in livestock

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Health Market, by Animal Type

  • 8.1. Companion Animals
    • 8.1.1. Cats
    • 8.1.2. Dogs
  • 8.2. Livestock
    • 8.2.1. Aquaculture
    • 8.2.2. Cattle
    • 8.2.3. Poultry
    • 8.2.4. Swine

9. Animal Health Market, by Product

  • 9.1. Diagnostics
    • 9.1.1. Immunological Diagnostics
    • 9.1.2. Molecular Diagnostics
  • 9.2. Feed Additives
    • 9.2.1. Enzymes
    • 9.2.2. Prebiotics
    • 9.2.3. Probiotics
  • 9.3. Parasiticides
    • 9.3.1. Ectoparasiticides
    • 9.3.2. Endoparasiticides
  • 9.4. Pharmaceuticals
    • 9.4.1. Branded
    • 9.4.2. Generics
  • 9.5. Vaccines
    • 9.5.1. Killed Inactivated
    • 9.5.2. Live Attenuated
    • 9.5.3. Recombinant

10. Animal Health Market, by Therapeutic Application

  • 10.1. Anti Infectives
    • 10.1.1. Antibiotics
    • 10.1.2. Antifungals
    • 10.1.3. Antivirals
  • 10.2. Anti Inflammatories
    • 10.2.1. Corticosteroids
    • 10.2.2. NSAIDs
  • 10.3. Antiparasitics
    • 10.3.1. Ectoparasiticides
    • 10.3.2. Endoparasiticides
  • 10.4. Hormonal Therapeutics
    • 10.4.1. Growth Hormones
    • 10.4.2. Reproductive Hormones

11. Animal Health Market, by Distribution Channel

  • 11.1. Online Stores
    • 11.1.1. Direct To Consumer Websites
    • 11.1.2. Third Party Platforms
  • 11.2. Retail Pharmacies
    • 11.2.1. Chain Pharmacies
    • 11.2.2. Independent Pharmacies
  • 11.3. Veterinary Hospitals And Clinics
    • 11.3.1. Large Animal Hospitals
    • 11.3.2. Small Animal Clinics

12. Animal Health Market, by End User

  • 12.1. Animal Owners
    • 12.1.1. Livestock Farmers
    • 12.1.2. Pet Owners
  • 12.2. Feed Manufacturers
  • 12.3. Veterinarians
    • 12.3.1. Large Animal Veterinarians
    • 12.3.2. Mixed Practice Veterinarians
    • 12.3.3. Small Animal Veterinarians

13. Animal Health Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Animal Health Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Animal Health Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Zoetis Inc.
    • 16.3.2. Merck & Co., Inc.
    • 16.3.3. Boehringer Ingelheim International GmbH
    • 16.3.4. Elanco Animal Health Incorporated
    • 16.3.5. IDEXX Laboratories, Inc.
    • 16.3.6. Ceva Sante Animale S.A.
    • 16.3.7. Vetoquinol S.A.
    • 16.3.8. Virbac S.A.
    • 16.3.9. Dechra Pharmaceuticals PLC
    • 16.3.10. Phibro Animal Health Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL HEALTH MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANIMAL HEALTH MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ANIMAL HEALTH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ANIMAL HEALTH MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ANIMAL HEALTH MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANIMAL HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANIMAL HEALTH MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL HEALTH MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 315. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 316. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 317. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 318. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 319. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 320. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 321. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 322. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 323. GLOBAL ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 324. GLOBAL ANIMAL HEALTH MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 325. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2024 (USD MILLION)
  • TABLE 326. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2025-2032 (USD MILLION)
  • TABLE 327. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 328. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 329. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 330. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 331. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 332. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 333. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 334. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 335. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 336. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 337. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS,